The success of Sildenafil initially drove a surge for pharma, nevertheless recent changes present a murky picture for investors. Generic competitors are eroding revenue, and ongoing patent challenges add additional https://keziaeuvo886071.blogoscience.com/47895994/viagra-and-big-pharma-a-precarious-play